Udayavni Special

Zydus Cadila receives DCGI nod for NAFLD drug in India


Team Udayavani, Dec 30, 2020, 11:05 AM IST

New Delhi: Drug firm Zydus Cadila on Wednesday said it has received approval from the Drug Controller General of India (DCGI) for Saroglitazar Mg, used for the treatment of non-alcoholic fatty liver disease (NAFLD), in the country.

The Drug Controller General of India (DCGI) has approved the new drug application (NDA) for Saroglitazar Mg for the treatment of non-alcoholic fatty liver disease (NAFLD) in India, Zydus Cadila said in a regulatory filing.

Zydus Cadila said the prevalence of NAFLD in India is estimated to be nearly 25-30 per cent of the general population.

Non-Alcoholic Fatty Liver Disease (NAFLD) is a progressive disease of the liver, which starts with fat accumulation in the liver in patients who do not consume alcohol or take it in insignificant amounts, but have risk factors such as overweight or obesity, diabetes mellitus (high blood sugar), hypertension (high blood pressure) or dyslipidemia (abnormal blood lipids).

This NAFLD condition could progress to NASH, cirrhosis and liver failure.

It is a large unmet medical need as there is currently no approved drug for the treatment of NAFLD and NASH anywhere in the world, Zydus Cadila said.

Pankaj Patel, the Chairman of Zydus Group, said with Saroglitazar Mg, the company has been able to successfully offer an innovative medicine for dealing with chronic liver diseases like NAFLD and NASH and helping patients in leading healthier lives.

Saroglitazar Mg was launched in India in September 2013, for the treatment of diabetic dyslipidemia and hypertriglyceridemia in patients with type-2 diabetes not controlled by statins alone.

In January this year, Saroglitazar Mg received an approval for the treatment of Type 2 Diabetes Mellitus. In March 2020, Saroglitazar Mg had received approval for the treatment of NASH.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

K’taka COVID-19 update: 501 new cases, 665 discharges, 4 deaths on Jan 19

IPL 2021: RCB retains 12 players from IPL 2020

Eatery at Pune launches a contest, eat 4kg thali and win Royal Enfield Bullet

Ramalinga Reddy, Dhruva Narayana selected as KPCC Working Presidents

Get set for rebuilding lives and expedite developmental works: CM BSY to officials

Cong leaders detained after trying to lay siege to Raj Bhavan in Bengaluru

Biden’s immigration bill proposes to eliminate per country cap, to benefit Indian IT professionals


Related Articles More

Trade unions ask govt to put on hold implementation of 4 labour codes

Cairn says engaged with Indian govt on adherence to arbitration award

Auto dealers’ body urges FM to introduce vehicle depreciation benefits for individuals in Budget

Eateries demand to rationalise GST on food delivery biz to 5%

Budget 2021: PM Modi to chair all-party meeting on Jan 30

MUST WATCH

Service on Wheels: Government services at one’s doorstep

Homemade Toy Electric Car using Waste Materials

Ullal: Condom found in donation box

Karunakar Kotegar | How to teach forgiveness | Udayavani

Arnab-Gupta WhatsApp chat leak!! New story, much misery…

Latest Additions

K’taka COVID-19 update: 501 new cases, 665 discharges, 4 deaths on Jan 19

IPL 2021: RCB retains 12 players from IPL 2020

COVID-19 vaccines sent by India reach Bhutan and Maldives

Former Arunachal Pradesh governor Mata Prasad passes away

Unsold ticket makes Kerala lottery seller crorepati

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.